Insider · CIK 0001866270
Lynne Fahey McGrath
Files at ALZN (Alzamend Neuro, Inc.). First filing Oct 24, 2025, latest Oct 24, 2025.
In brief
Lynne Fahey McGrath files SEC Form 4 as director at ALZN (Alzamend Neuro, Inc.). Since Oct 24, 2025, Lynne Fahey McGrath has reported 0 open-market buys worth $0 and 1 open-market sell worth $69, the latest filed on Oct 24, 2025.
A track record needs three past buys with six months of prices behind them; Lynne Fahey McGrath has 0, so none is measured yet.
The newest scored trade: sold $69 of ALZN on Oct 23, 2025, filed Oct 24, 2025, scored 35 (weak). In the last 12 months: 0 buys worth $0 and 1 sell worth $69.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ALZN: Alzamend Neuro, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | ALZNsell Alzamend Neuro, Inc. | $69 30 shares | -55% | +7% from low-84% from high |
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 23, 2025 | ALZN Alzamend Neuro, Inc. | SOpen-market sale Common Stock | -30 | $2.29 | $69 | 25 | Oct 24, 2025 |
Questions about Lynne Fahey McGrath
Answered from the filings on this page, as of the latest one.
Is Lynne Fahey McGrath buying or selling?
In the last 12 months Lynne Fahey McGrath reported 0 open-market buys worth $0 and 1 open-market sell worth $69 on SEC Form 4; the latest was sold $69 of ALZN on Oct 23, 2025. Grants, option exercises and tax withholding are not counted.
How did Lynne Fahey McGrath's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Lynne Fahey McGrath has 0.
Where does Lynne Fahey McGrath file Form 4?
Lynne Fahey McGrath has filed Form 4 at ALZN (Alzamend Neuro, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.